WASHINGTON, DC—Coronary CT angiography (CCTA) seems to have the edge over functional testing for the assessment of suspected CAD in patients with newly diagnosed type 2 diabetes, real-world data show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback